कुक्कुट, मत्स्य पालन और वन्यजीव विज्ञान
खुला एक्सेस

अमूर्त

The High Cost of Pesticides: Human and Animal Diseases

Judy Hoy, Nancy Swanson and Stephanie Seneff*

A significant degradation in the health of wild animals in Montana has been recorded over the past two decades. We surmise that the health issues are related to pesticide exposure. We present some of the evidence of the deterioration of the health in wildlife, which we used to inspire investigations on human health in the US population. While the animals’ exposure is through food, water and air, we believe that human exposure is predominantly through food, as the majority of the population does not reside near agricultural fields and forests. We have obtained US government data on pesticide usage and on human disease patterns over time from the 1998-2010 hospital discharge data. Since glyphosate is by far the most widely used herbicide, we believe it to be a major source of contamination for humans. Correlations between glyphosate usage and specific health issues, along with the known toxicology profile of glyphosate obtained from the literature, reflect a plausible causal relationship. Because much of the wildlife data is from deer fawns, most of the human data presented here involve newborn infants, but we also present some data for children 0-15 years old and for the full population (except newborn). We found many diseases and conditions whose hospital discharge rates match remarkably well with the rate of glyphosate usage on corn, soy, and wheat crops. These include head and face anomalies (R=0.95), newborn eye disorders, newborn blood disorders (R=0.92), newborn skin disorders (R=0.96), lymph disorders in children 0-15 (R=0.86) and in the general population except newborn (R=0.89), congenital heart conditions in newborns (R= 0.98), enlarged right ventricle in all age groups except newborn (R=0.96), newborn lung problems (R=0.95), pulmonary bleeding and edema for all age groups except newborn (R=0.97), liver cancer for all age groups except newborn (R=0.93), newborn metabolic disorders (R=0.95) and newborn genitourinary disorders (R=0.96).